Recent insights into the mechanisms of vasospastic angina

Sang-Yong Yoo1, Jang-Young Kim

  • 1Division of Cardiology, Department of Internal Medicine, University of Ulsan College of Medicine, Gangneung Asan Hospital, Gangneung, Korea.

Insights

Coronary artery spasm, linked to endothelial dysfunction and inflammation, contributes to ischemic heart disease. Understanding its mechanisms, including RhoA/ROCK pathways, is crucial for managing conditions like vasospastic angina.

Area of Science:

  • Cardiology
  • Vascular Biology
  • Pathophysiology

Background:

  • Coronary artery spasm is implicated in ischemic heart disease, myocardial infarction, and sudden death, especially in Asian populations.
  • Vasospastic angina is associated with endothelial dysfunction, reduced nitric oxide bioavailability, elevated oxidative stress, and C-reactive protein.
  • Key risk factors include smoking, endothelial nitric oxide synthetase (eNOS) gene polymorphisms, and low-grade inflammation.

Purpose of the Study:

  • To review the current understanding of the mechanisms underlying coronary artery spasm.
  • To explore the role of endothelial dysfunction and vascular smooth muscle hypercontraction in vasospastic angina.

Main Methods:

  • Literature review of current research on coronary artery spasm mechanisms.
  • Analysis of evidence linking endothelial nitric oxide synthetase (eNOS) and RhoA/ROCK pathways to coronary vasospasm.

Main Results:

  • Endothelial dysfunction, characterized by reduced nitric oxide bioavailability, is a significant factor.
  • The RhoA/ROCK pathway is implicated in vascular smooth muscle hypercontraction and regulation of eNOS activity.
  • Oxidative stress and inflammation markers are elevated in patients with vasospastic angina.

Conclusions:

  • Endothelial dysfunction and enhanced vascular smooth muscle contractility are major mechanisms in vasospastic angina.
  • While significant progress has been made, precise mechanisms of coronary vasospasm require further elucidation.
  • Understanding these pathways is critical for developing effective therapeutic strategies for ischemic heart disease.

Related Concept Videos

Angina II: Classification01:27

Angina II: Classification

Angina, also known as angina pectoris, is a chest pain resulting from diminished blood flow to the heart muscle and is often a symptom of coronary artery disease. Angina presents several variants with distinctive attributes, etiologies, and therapeutic approaches. The main types of angina include stable, unstable, variant (Prinzmetal's), microvascular, intractable, and silent ischemia.Stable angina is caused by atherosclerosis, which leads to the formation of plaques that narrow the coronary...
Angina III: Clinical Manifestations and Assessment01:29

Angina III: Clinical Manifestations and Assessment

Angina manifests as chest pain, tightness, or squeezing discomfort typically located behind the breastbone. It can radiate to the neck, jaw, shoulders, and inner aspects of the upper arms, most commonly the left arm. Patients may experience shortness of breath, fatigue, profuse sweating, dizziness, indigestion, heartburn, palpitations, anxiety, and vomiting as accompanying symptoms. This pain often lasts a few minutes and is triggered by physical exertion, emotional stress, heavy meals, or cold...
Angina I: Introduction01:30

Angina I: Introduction

Definition and Symptoms: Angina (angina pectoris) is chest pain or discomfort caused by myocardial ischemia, which occurs when the heart muscle receives insufficient oxygen-rich blood. It typically manifests as pressing, squeezing, or crushing sensations in the chest and may radiate to the shoulders, arms, neck, jaw, or back.Primary Cause: In a healthy state, the coronary arteries can dilate (widen) to increase blood flow and meet the increased oxygen demand during physical activity or...
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
Antianginal Drugs: Calcium Channel Blockers and Ranolazine01:25

Antianginal Drugs: Calcium Channel Blockers and Ranolazine

Angina pectoris, a primary symptom of ischemic heart disease, requires careful pharmacological interventions. In this context, calcium channel blockers (CCBs) and ranolazine have emerged as crucial pharmacotherapeutic agents, providing deep insights into the complexities of angina management.
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
Vascular Spasm01:16

Vascular Spasm

The vascular phase, also known as vasospasm, is the initial stage of hemostasis, crucial for preventing excessive bleeding when a blood vessel is injured. After a vessel is cut, nerves in the damaged area trigger pain and other sensory impulses. Simultaneously, the smooth muscles in the vessel wall contract, resulting in a vascular spasm. This contraction reduces the vessel's diameter at the injury site, slowing or stopping blood loss through the vessel wall. Vascular spasms typically last for...